Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2002

View Archived Issues

Paxil approved in Canada for posttraumatic stress disorder

Zycos and Pharmexa sign cancer vaccine formulation agreement

Tachykinin NK1 antagonists identified at Merck

New factor Xa inhibitors patented by Sankyo

Novel antifungal agents in the BMS pipeline

Agents with dual AChE-inhibitory/antioxidant activity for use in AD

Bayer describes IkappaB kinase inhibitors as potential antiasthmatic agents

Chemokine receptor modulators claimed by AnorMED

Update on status of T-614, a new antiarthritic drug

JT to advance three products to phase III by March 2004

Novel adenoviral vector efficiently delivers E1A to tumor cells and reduces tumorigenic capacity

Locally administered AS ODN targeting a common cytokine receptor subunit for asthma

Diabetic fruit flies may provide new information on the development of human pancreatic beta-cells

Synergistic effects of the CCR5 antagonist SCH-C combined with other antiretroviral drugs

Crosslinking of thymosin beta4 to fibrin may underlie wound healing

Rho kinase as a potential target for erectile dysfunction Rx

Corixa to request appeal to FDA stance on Bexxar

Novel treatments for male erectile dysfunction

BioMarin initiates preclinical studies of NeuroTrans brain delivery technology

Mimotopes and Baker Medical Research Institute to develop novel cardiovascular drugs

RSV antibody production in greenhouse plant lines

Antistaphylococcal monoclonal antibody provides encouraging phase I results

BTG acquires HIV treatment technology from BioClonetics

ATL-104 safe and well tolerated in phase Ib trial

CeNeS updates progress of key pain products

T-20 provides positive 24-week results in second phase III HIV study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...